Stay updated on Clinical Trial: Benfotiamine in Alzheimer's Disease
Sign up to get notified when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.

Latest updates to the Clinical Trial: Benfotiamine in Alzheimer's Disease page
- Check6 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about replacing “Artificial Intelligence” with “Super Intelligence” under Executive Order 14434.SummaryDifference1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1. The study page itself remains a 403 error page.SummaryDifference0.2%

- Check20 days agoChange DetectedThe site’s footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, restricting access to the entry and its details. Navigation and site chrome remain visible, but the study content is inaccessible.SummaryDifference19%

- Check62 days agoChange DetectedThe page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a software update without changes to the study information.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, updating the page's revision metadata. This update does not change the study content or user-facing information.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Benfotiamine in Alzheimer's Disease
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Benfotiamine in Alzheimer's Disease page.